# INSULET CORPORATION (PODD) · Edgar & Edgarette company card

> Insulet (PODD) grew revenue 30.7% in FY2025 to $2.7 billion, operating margin 17.5% against a 1.2% median for surgical & medical instruments & apparatus, equity 47.5% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1145197 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/PODD) · [JSON](https://www.pops4.com/boards/company/PODD.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $2.7B |
| Revenue growth, 1 year | 30.7% |
| Revenue growth per year | 25.3% |
| Operating margin | 17.5% (prior year 14.9%) |
| Net margin | 9.1% |
| Operating cash flow | $569M |
| Capital spending | $192M |
| Free cash flow | $378M |
| Cash | $716M |
| Long-term debt | $949M |
| Total assets | $3.2B |
| Total equity | $1.5B |
| Equity ÷ assets | 47.5% |
| Return on equity | 16.3% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: 4.78 (safe zone)
- Piotroski F: 7 of 9 (solid)
- Health Harbor boat: Sound ship · one warning sign · filed auditor change in the last 12 months
- Cash Compass: Cash cow later · growing fast, and already turning revenue into cash

## Edgarette's reading

Exposure: revenue $2.7B (FY2025), total debt $949.2M. Experience: revenue up 30.7% on the year, up 25.3% a year over 4 years; operating margin 17.5%, up from 14.9%. Soundness: equity 47.5% of assets, return on equity 16.3%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $3.1B and $3.8B next year (method v4.1: its own 4-year record of growth weighed at 50% against $1B–10B filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $2.9B to $4.0B. A statistical range, not company guidance. Against peers (60 filers, $50M+ revenue, surgical & medical instruments & apparatus): operating margin 17.5% against a 1.2% median; growth 30.7% against 11.6%.

Range logged 2026-09-24, receipt 6b0d4dd1fdb90cdc, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 4.01 Auditor change: 1, latest 2025-12-19 ([filing](https://www.sec.gov/Archives/edgar/data/1145197/000162828025058252/0001628280-25-058252-index.htm))
- Item 5.02 Director or officer change: 5, latest 2026-09-16 ([filing](https://www.sec.gov/Archives/edgar/data/1145197/000114519726000177/0001145197-26-000177-index.htm))

## Recent filings

- 8-K · filed 2026-11-04 · 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1145197/000114519726000190/0001145197-26-000190-index.htm)
- 8-K · filed 2026-09-21 · 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1145197/000119312526396779/0001193125-26-396779-index.htm)
- 8-K · filed 2026-09-16 · 5.02 Departure or Election of Directors; Appointment of Officers; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1145197/000114519726000177/0001145197-26-000177-index.htm)
- 8-K · filed 2026-09-10 · 5.02 Departure or Election of Directors; Appointment of Officers · [filing](https://www.sec.gov/Archives/edgar/data/1145197/000114519726000175/0001145197-26-000175-index.htm)
- 10-Q · filed 2026-08-05 · [filing](https://www.sec.gov/Archives/edgar/data/1145197/000114519726000169/0001145197-26-000169-index.htm)
- 8-K · filed 2026-08-05 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1145197/000114519726000167/0001145197-26-000167-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001145197.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1145197

## Cite

POPS4, Edgar & Edgarette: INSULET CORPORATION (PODD) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/PODD. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.